Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-20-001301
Filing Date
2020-05-22
Accepted
2020-05-22 16:10:31
Documents
2
Period of Report
2020-05-20

Document Format Files

Seq Description Document Type Size
1 form4-05222020_040515.html 4  
1 form4-05222020_040515.xml 4 4213
2 ex24-05222020_040517.htm EX-24 6909
  Complete submission text file 0001415889-20-001301.txt   12735
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 210 ALLANDALE ST #1B CHESTNUT HILL MA 02467
Business Address
Avnur Zafrira (Reporting) CIK: 0001726049 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 20905940